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The hippocampus is one of the earliest affected brain regions in Alzheimer’s disease
(AD) and its dysfunction is believed to underlie the core feature of the disease-memory
impairment. Given that hippocampal volume is one of the best AD biomarkers, our
review focuses on distinct subfields within the hippocampus, pinpointing regions that
might enhance the predictive value of current diagnostic methods. Our review presents
how changes in hippocampal volume, shape, symmetry and activation are reflected by
cognitive impairment and how they are linked with neurogenesis alterations. Moreover,
we revisit the functional differentiation along the anteroposterior longitudinal axis of
the hippocampus and discuss its relevance for AD diagnosis. Finally, we indicate that
apart from hippocampal subfield volumetry, the characteristic pattern of hippocampal
hyperactivation associated with seizures and neurogenesis changes is another promising
candidate for an early AD biomarker that could become also a target for early
interventions.
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Alzheimer’s disease (AD) is the most common type of dementia
in people over the age of 65, with a lifetime risk of 10.5% (Sperling
et al., 2011). In 2013, there have been 44.35 million people affected
by dementia worldwide and their number will reach 75.62 million
in 2030 (Alzheimer’s Disease International, 2013). AD encom-
passes pre-dementia and dementia stage. It is characterized by
a long asymptomatic period that transforms into mild cognitive
impairment (MCI) and later to dementia due to AD.
Individuals with MCI are affected by significant cognitive
impairments which are not sufficient to meet AD criteria but
are beyond normal healthy aging features. The amnestic subtype
of MCI (aMCI) is characterized by a higher likelihood of pro-
gressing to dementia (Petersen et al., 2009). However, the annual
conversion rate is 5–10% and the majority of MCI individuals
even after 10 years will not progress to clinical AD, or some
will even improve cognitively (Mitchell and Shiri-Feshki, 2009).
Therefore, the possibility to predict who from the MCI group
will eventually progress to AD would be invaluable for planning
patients’ therapy, counselling and clinical trials. Therefore, given
that the neurodegenerative process leading to dementia due to
AD begins more than a decade before clinical diagnosis is made
(Jack et al., 2013), there is a quest for reliable techniques and
biomarkers enabling diagnosis at the preclinical stage to pro-
vide opportunity for therapeutic intervention. These methods
need to be widely available and relatively inexpensive to find
application in the diagnosis of the millions of affected individuals
worldwide.
With an integrative perspective of molecular and cellular biol-
ogy as well as neuroanatomy, our review focuses on the recent
advancements in hippocampal analyses employing widely avail-
able magnetic resonance imaging (MRI) scanners, and describes
how it might impact on improved early AD diagnosis.
We discuss why looking solely at the hippocampal volume is
not sufficient to diagnose early stage AD. We present the latest
data on the hippocampal changes in AD and suggest how they
can be employed to diagnose AD earlier than we have been
doing so far. To our knowledge, our review is the first one
to provide a comprehensive summary of neuroimaging studies
focused on hippocampal subfields in the context of AD. We
highlight the subfields that might enhance the predictive value of
current diagnostic techniques. Moreover, we present how changes
in hippocampal volume, shape, symmetry and activation are
reflected by cognitive impairment as well as neuropsychiatric
symptoms, and how they are linked with neurogenesis alterations.
We discuss how measuring these changes might be applied in AD
diagnosis. In addition, we demonstrate why both hippocampal
neurogenesis and functional differentiation along the anterior-
posterior longitudinal axis of the hippocampus deserve more
attention in future studies by presenting their relevance for
presymptomatic AD diagnosis. Finally, we indicate that apart
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from hippocampal subfield volumetry, the characteristic pattern
of hippocampal hyperactivation associated with seizures and neu-
rogenesis changes is a very promising candidate for both an early
AD biomarker and target for early pharmacological interventions.
The hippocampus is composed of interconnected subfields
with distinctive histological characteristics and specialized func-
tions, including four fields of the Cornu Ammonis (CA1-4),
dentate gyrus (DG) and the subiculum. The nomenclature of hip-
pocampal subfields and their anatomical definitions vary among
different authors, however, there is even less agreement on the
location of boundaries between hippocampal head, body and tail.
The hippocampus has two major interconnected roles. It is
involved in consolidation of some forms of memory, learning and
emotional processing. It encompasses also one of the brain niches
where adult neurogenesis occurs, i.e., in subgranular zone of the
DG. Neurogenesis is essential for memory, learning and mood
(Deng et al., 2010; Eisch and Petrik, 2012; Zainuddin and Thuret,
2012) and there is extensive evidence showing that these processes
are altered in AD (Lazarov and Marr, 2013; Maruszak et al., 2013).
We discuss further the link between changes in the hippocampus
and neurogenesis alterations.
STRUCTURAL CHANGES IN THE HIPPOCAMPUS AS ONE OF
AD HALLMARKS
In most cases, AD is diagnosed when the hippocampus is already
considerably damaged. The hippocampus is one of the major
targets of AD hallmarks: neurofibrillary tangles (NFT), amyloid
plaques and neuronal loss. NFT are intraneuronal aggregates of
hyperphosphorylated microtubule-associated protein, tau. Their
number and spatiotemporal distribution correlates positively
with cognitive decline and progression of AD (Braak et al.,
1998). First, they affect the brain in the entorhinal/perirhinal
cortex, thereby disrupting the origin of the perforant pathway
projection to the hippocampus. Then NFT target hippocampal
cornu Ammonis (CA) subfields, association cortex, and finally
primary neocortex. In the hippocampus NFT target first CA1,
then subiculum, later CA2 and CA3 (Braak and Braak, 1991;
Braak et al., 1993). NFT are paralleled by neuronal and synapse
loss, although it remains unclear whether NFT are causative for
these changes or represent a neuroprotective response (Serrano-
Pozo et al., 2011). The spatiotemporal spreading of NFT is
closely reflected by the progression of brain atrophy, and both
NFT and atrophy measures strongly correlate with cognitive
decline (Bobinski et al., 2000; Jack et al., 2002; Johnson et al.,
2012).
The extracellular amyloid plaques, which are composed of
aggregated amyloid β (Aβ) peptides of 39–42 amino acids in
length, display less predictable spatiotemporal distribution than
NFT. They accumulate mainly in the isocortex and their presence
does not correlate with dementia severity (Braak and Braak, 1991;
Thal et al., 2002; Giannakopoulos et al., 2003).
The third characteristic feature of AD, the progressive cerebral
atrophy, encompasses hippocampal atrophy and can be visualized
by MRI. For the majority of AD patients (with the exclusion of
those with hippocampal sparing and limbic-predominant AD)
hippocampal atrophy is one of the earliest detectable symptoms
of ongoing neurodegeneration, thus it has been incorporated in
the new diagnostic criteria for AD (Mormino et al., 2009; Dubois
et al., 2010; Lo et al., 2011; Jack et al., 2013). Hippocampal
atrophy progresses nonlinearly, expressing features of a sigmoidal
trajectory as it accelerates during transition from MCI to AD
dementia (Sabuncu et al., 2011; Jack et al., 2013). It starts to
diverge from normal rate of atrophy around 5.5 years before
clinical diagnosis of dementia (Ridha et al., 2006). Already 3 years
before diagnosis hippocampal volume is reduced by about 10%,
whereas AD patients at the mild disease stage are characterized
by the volume reduced by∼15–20% relative to controls (Johnson
et al., 2012).
Hippocampal volume is strongly associated with memory
recall performance in the elderly (Reitz et al., 2009). Likewise, in
aMCI, MCI and AD hippocampal atrophy positively correlates
with measures of cognitive decline, such as Mini-mental state
examination (MMSE) or Alzheimer’s Disease Assessment Scale-
Cognitive Subscale (ADAS-Cog; Pennanen et al., 2004; Jessen
et al., 2006; Jak et al., 2007; Schuff et al., 2009; Sabuncu et al.,
2011; Frankó and Joly, 2013). AD patients are characterized by
higher average rate of hippocampal volume loss than healthy age-
matched controls, whereas MCI patients have an intermediate
level of volume loss between AD and control individuals (Schuff
et al., 2009). Moreover, hippocampal atrophy in MCI converters is
more pronounced compared to non-converters (Devanand et al.,
2007; Kantarci et al., 2009; Risacher et al., 2009; Costafreda et al.,
2011).
It has been proposed that surface-based methods enabling
three-dimensional hippocampal shape analysis might serve as a
better tool to localize early hippocampal atrophy. This technique
estimates surface changes which enable localisation of regions
of highest inward and outward transformations. Hippocampal
shape is predictive for dementia in the preclinical period, inde-
pendently of age and gender (Achterberg et al., 2013). Moreover,
combining both shape and volume enables better prediction of
the risk of dementia (Achterberg et al., 2013). However, the
surface-based methods have also some important drawbacks
which will be discussed further in this review.
FACTORS AFFECTING HIPPOCAMPAL VOLUME IN AD
Hippocampus is a dynamic structure and there are several factors
that influence its volume. First of all, hippocampal volume has
been shown to be highly heritable as a recent meta-analysis of
genome-wide association studies revealed (Stein et al., 2012).
Moreover, there were also suggestions of ApoE epsilon4 (APOE4)
effect on hippocampal volume. Together with some other AD risk
factors, such as elevated homocysteine level, APOE4 was associ-
ated with smaller hippocampal size and changes in hippocampal
asymmetry (described below). For instance, Schuff et al. reported
that the volume loss in AD patients was significantly higher if
they were carriers of APOE4 allele compared to APOE4 non-
carriers, irrespective of their cognitive impairments (Schuff et al.,
2009). APOE4 status was not associated with higher hippocampal
volume loss in healthy controls or MCI patients (Schuff et al.,
2009). Mueller and Weiner (2009) have shown that both AD
patients and controls that were carriers of APOE4 exhibit hip-
pocampal volume loss specifically in CA3 and DG compared
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to non-carriers (Mueller and Weiner, 2009). Despite the long
list of the APOE4 roles in functional and gray matter changes
throughout adulthood as it has been shown to play an important
role in neuronal development, neuron migration, axon guidance,
microtubule stability, dendritic spine density, synaptic plasticity,
and regeneration after injury and in adult neurogenesis (Yang
et al., 2011; Dean et al., 2014), there are also studies that do
not find positive association of APOE4 allele with hippocampal
volume changes (Reitz et al., 2009; Wang et al., 2012) or that
APOE4 influences not the hippocampal volume but the rate of
volume loss over time (Moffat et al., 2000; Cohen et al., 2001;
Jak et al., 2007; Lyall et al., 2013). The discrepancies may stem
from methodological variability between the studies, such as for
instance different sample sizes or different approaches to compar-
ing APOE genotypes.
Among other factors affecting hippocampal volume is age,
thus hippocampus is independently affected both by age and AD
pathology (Raz et al., 2005; Raji et al., 2009). In addition, many
age-related pathological conditions, of which many increase AD
risk, such as e.g., hypertension, diabetes mellitus, cardiovascular
disease and head trauma, influence hippocampal volume (Fotuhi
et al., 2012). Moreover, hippocampal volume might be affected
by medications. For instance, antidepressants or cholesterol-
lowering treatment have been shown to help reverse hippocampal
atrophy (Fotuhi et al., 2012).
Among the factors increasing hippocampal volume is cognitive
stimulation, mindfulness and aerobic exercise (for review see
Fotuhi et al., 2012). The latter one has been linked with increased
both right and left hippocampal volume by around 2% over
1 year and reversing age-related hippocampal shrinkage as well
as improving cognition (Erickson et al., 2011). In a 9-year long
prospective cohort study, it has been shown that regular physical
activity, as simple as walking, increases hippocampal volume,
and in addition, larger hippocampal volume was associated with
decreased risk of cognitive impairment (Erickson et al., 2010).
The influence of aerobic exercise on hippocampal volume might
be of particular interest of individuals at risk of AD, as it seems
to selectively increase the volume of the anterior hippocampus,
which is affected early on in AD course (Erickson et al., 2011).
Moreover, there is also extensive evidence of the role of exercise
in increasing hippocampal neurogenesis as it increases prolifer-
ation and survival of hippocampal progenitor cells (Cotman and
Berchtold, 2002; van Praag et al., 2005; Creer et al., 2010). Notably,
the remaining above-mentioned factors influencing hippocam-
pal volume have been also implicated in neurogenesis. Recently,
another common factor between neurogenesis and hippocampal
volume has been revealed—brain-derived neurotrophic factor,
which level is decreased in AD as well as in impaired neurogenesis
(Honea et al., 2013).
HIPPOCAMPAL ASYMMETRY IN AD
Although hippocampus is structurally and functionally asym-
metric, right (R) vs. left (L) hippocampal volume differences
have received less research attention. In healthy adults there is
hemispheric asymmetry of the whole hippocampus, with larger
volume of the right one (Pedraza et al., 2004; Shi et al., 2009).
There are also right vs. left differences in the layers’ thickness and
volumes of different hippocampal subfields. For instance, Lister
et al. identified asymmetries in neuronal numbers in rat CA1 and
CA3/CA2 subfields, with the right hemisphere containing 21 and
6% fewer neurons, respectively (Lister et al., 2006).
Hippocampal volume asymmetry has been connected with
cognitive functions and it has been suggested that hippocampal
subfields analysis should be included in these correlation studies.
For instance, Woolard and Heckers (2012) in a study of 110
healthy individuals of 32.3 ± 10.7 years of age demonstrated that
the R > L asymmetry is limited to the anterior hippocampus
and it is correlated with a measure of general cognitive functions
(Screen for Cognitive Impairment in Psychiatry) (Woolard and
Heckers, 2012). Moreover, they showed that the volume of ante-
rior hippocampus correlates with the volumes of all four cortical
lobes, whereas the posterior hippocampus volume was found
strongly correlated with the volume of occipital cortex (Woolard
and Heckers, 2012).
A meta-analysis indicated that in AD there is a significant
R > L hippocampal volume asymmetry as compared to the con-
trol group (Barnes et al., 2005; Shi et al., 2009). Given that hip-
pocampal asymmetry might be due to genetic, developmental and
environmental factors (Verstynen et al., 2001; Tang et al., 2008),
hippocampal asymmetry in AD has been suggested to be influ-
enced by the dose effect of the APOE4 allele; the R > L asymmetry
is progressively reduced and even reversed in APOE4/4 carriers
affected by AD (Geroldi et al., 2000). It has been also postulated
that the left hippocampus is more vulnerable than the right one
to AD pathology due to already smaller volume (Muller et al.,
2005). Nevertheless, hippocampal asymmetry changes with AD
progression, with the left hippocampus affected first by dementia,
followed by atrophy in the right hippocampus after a time lag
(Thompson et al., 2004; Morra et al., 2009b). Finally, one needs
to be mindful of the limitations associated with using manual
asymmetry measurements. Recently, Maltbie et al. performed a
semi-automatic hippocampal segmentation and pointed out that
neuroimaging is typically biased to one side due to laterality in
visual perception (Maltbie et al., 2012). Although this bias has
been reported to be smaller than the true anatomical R > L
hippocampal asymmetry values (for further information on this
topic and hints on avoiding the potential bias, please refer to work
by Rogers et al., 2012), it is worth to take it into consideration
while interpreting hippocampal asymmetry data.
THE SUPREMACY OF SUBFIELD ANALYSIS OVER TOTAL HIPPOCAMPAL
VOLUME MEASUREMENTS FOR AD DIAGNOSIS
Similarly to other AD biomarkers, application of hippocampal
volume changes for AD diagnosis has some limitations. Although
there is a higher rate of global hippocampal volume loss in
AD patients compared to control individuals and MCI patients,
changes in hippocampal volume show moderate sensitivity and
low specificity to AD as it is observed also in other conditions
such as semantic dementia (Frisoni et al., 2010; Lindberg et al.,
2012; Tondelli et al., 2012; La Joie et al., 2013). Sensitivity of
total volume analysis is restricted to the stages from MCI to
moderate dementia stage (Frisoni et al., 2010). In the asymp-
tomatic AD the markers of Aβ deposition (carbon 11-labeled
Pittsburgh Compound B (PiB) positron emission tomography
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(PET), cerebrospinal fluid (CSF) Aβ42) have been suggested to
outperform markers of structural changes but their values plateau
by MCI stage (Frisoni et al., 2010).
Given that the hippocampal subfields are differentially vulner-
able to neuropathology in AD and their measurements have been
shown to be more accurate than global hippocampal volumetry to
differentiate prodromal AD (aMCI) from cognitively normal con-
trols (La Joie et al., 2013), it has been proposed that hippocampal
subfield volumetry might be a better biomarker for early detection
of AD.
AD is characterized by the most prominent neuron loss in
CA1 which correlates with dementia severity and Braak staging
(Rossler et al., 2002; Mueller et al., 2010). Other studies indi-
cated that apart from smaller volume of CA1, AD patients have
decreased size of entorhinal cortex (EC), subiculum and CA1-2
transition zone (Mueller and Weiner, 2009; Mueller et al., 2010;
Apostolova et al., 2012) and these findings are consistent with the
level of neuronal loss (West et al., 2004; Zarow et al., 2005).
Likewise, owing to differences between studies such as age
of participants, applied segmentation protocols, MRI resolution,
limited statistical power and small effect sizes, there are still con-
troversies as to which hippocampal subfield is the most reliable
to distinguish normal healthy controls from aMCI. For instance,
CA1 is the earliest affected hippocampal subfield by NFT and
neuronal loss (Braak and Braak, 1991; Braak et al., 1993; West
et al., 1994) and it has been shown to remain relatively preserved
in healthy aging, thus it has been proposed that CA1 atrophy
might be a biomarker of presymptomatic AD (Csernansky et al.,
2005; Scher et al., 2007; Frisoni et al., 2008; Gerardin et al., 2009;
Raji et al., 2009; Apostolova et al., 2010; La Joie et al., 2010).
However, there are other candidates for the area of the largest
difference between aMCI and controls, as some indeed point to
CA1 (Yassa et al., 2010; Pluta et al., 2012; La Joie et al., 2013),
however, others suggest that it is CA1-2 transition area (Mueller
and Weiner, 2009; Mueller et al., 2010) but subiculum and CA2-3
(Hanseeuw et al., 2011) or CA3/DG (Yassa et al., 2010) have
been also proposed. Some researchers did not focus on aMCI
but on the whole MCI instead. Apostolova et al. (2006) showed
that MCI patients with smaller hippocampi, particularly in the
CA1 and subiculum, are at a higher risk of converting to AD
(Apostolova et al., 2006). Moreover, MCI individuals that improve
cognitively and revert to control status are characterized by larger
hippocampal volumes and relative sparing of CA1 and subiculum
(Apostolova et al., 2006). In addition, in a later study Apostolova
et al. reported that the most pronounced differences between MCI
and AD were in CA1 and CA2-3 bilaterally (Apostolova et al.,
2012). Although there is no general agreement about the potential
role of CA1 in AD diagnosis, it has been shown that the CSF
tau and Aβ42 concentrations at baseline correlate with the rate
of hippocampal atrophy and progressive inward deformations of
the CA1 subfield in the individuals at the very mild stage of AD
(Clinical Dementia Rating 0.5; Wang et al., 2012).
In general, the problem with modelling hippocampal volume
or hippocampal subfields volume changes in AD is that neuronal
loss is detected only in some AD mouse models. Some tg-mice
exhibit CA1 pyramidal neuron loss (i.e., Wright et al., 2013;
Beauquis et al., 2014), however there are also reports of no change
in number of neurons (Schaeffer et al., 2011). For instance, in
PDAPP mice at 5 months of age (before the appearance of amyloid
plaques in the hippocampus and cortex), a 12% decrease in CA1
and 25% reduction in DG volume was detected (Beauquis et al.,
2014). Smaller DG size in PDAPP mice has been reported also by
their researchers (Redwine et al., 2003; Wu et al., 2004). Atrophy
of CA3/DG has been found in aMCI patients (Yassa et al., 2010;
Atienza et al., 2011). However, in MCI and AD patients there have
been no reports of sole DG atrophy. Mueller et al. (2010) argue
that it might be due to the fact that DG and CA3 are frequently
analysed together and owing to the relatively good preservation
of CA3 in AD, it is possible that it overshadows subtle effects
in DG (Mueller et al., 2010). Indeed, although surface-based
methods have similar prognostic performance to other struc-
tural neuroimaging approaches, these methods do not provide
quantitative information about hippocampal subfields volumes.
Moreover, as Pluta et al. argue, that automatic hippocampal
subfield segmentation basing on surface-based parcellation does
not adequately model the CA4/DG subfield, given that it is to a
substantial extent internal to the hippocampal formation (Pluta
et al., 2012). Therefore, changes in the hippocampal surface might
not truly reflect degeneration in DG.
ANTERIOR VS. POSTERIOR LOCATION OF HIPPOCAMPAL SUBFIELDS
AND THEIR ROLE IN AD
Another approach to looking at the hippocampus employs dif-
ferences in gene expression, behavior and functional connectiv-
ity, which were used to divide rodent hippocampus into three
gross anatomical subregions, following the longitudinal axis of
the hippocampus: dorsal, ventral and intermediate subfields (see
Poppenk et al., 2013 for detailed information about connectiv-
ity and detailed information about postulated differences along
dorsal-ventral axis; Moser and Moser, 1998; Fanselow and Dong,
2010; Zarei et al., 2013). These hippocampal regions correspond
to the septal, temporal and caudal poles in rat (Swanson and
Cowan, 1977). The septal pole, located dorsally and anteriorly in
rodents, corresponds to posterior hippocampus in humans (Tanti
and Belzung, 2013). The temporal pole, ventrally and posteriorly
located in rodents, is the anterior hippocampus in humans (Tanti
and Belzung, 2013). The intermediate subregion in humans is
often not distinguished (Poppenk et al., 2013).
These three hippocampal regions are characterized by different
patterns of connectivity with prefrontal cortex (PFC), posterior
cingulate cortex (PCC) and thalamus (Zarei et al., 2013). For
instance, connections between the hippocampus and PCC are
thought to be involved in autobiographical and episodic memory
(Zarei et al., 2013).
So far, there have been strong discrepancies in defining the
boundaries of the dorsal/ventral subregions (see review by Tanti
and Belzung, 2013). Frequently, little information regarding the
methodology behind distinguishing the dorsal and ventral sub-
fields is provided which prevents comparisons between studies.
Nevertheless, the major hippocampal subfields, such as CA1, CA3
and DG are segregated into dorsal, intermediate and ventral.
The most pronounced atrophy in AD has been found in
the anterior hippocampus (as well as posterior parahippocampal
gyrus and the precuneus) compared to age-matched controls
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(Raji et al., 2009). Moreover, hippocampal head (anterior) atro-
phy has been reported as a predictive marker of conversion to
AD (Csernansky et al., 2005; Apostolova et al., 2006; Morra et al.,
2009a; Costafreda et al., 2011). Costafreda et al. identified more
pronounced changes in the right lateral and medial aspects of
hippocampal head in individuals that later converted to AD and
his results correspond with previous reports of anterior CA1
(Csernansky et al., 2005; Apostolova et al., 2006; Costafreda et al.,
2011). Recently, Franko and Joly demonstrated that regions with
the highest atrophy rate in anterio-lateral hippocampus corre-
spond to those with highest tau deposition (Frankó and Joly,
2013). This supports the above-mentioned link between anterior
CA1 and conversion to AD.
In addition, AD patients exhibit weaker connectivity with the
PCC in the hippocampal body and stronger connectivity with the
PFC in the head of the hippocampus compared to the healthy
controls (Zhang et al., 2010; Zarei et al., 2013). Previous stud-
ies found disrupted functional connectivity with default mode
network (DMN) in AD (as it is not in the scope of this review,
please refer to Greicius et al., 2004; Mevel et al., 2011). Moreover,
diffusion tensor imaging (DTI) provided evidence that structural
connectivity between PCC and hippocampus is decreased during
the earlier stages of AD (Zhou et al., 2008). The differences in
the hippocampal connectivity were proposed to contribute to
cognitive deficits in AD (Zarei et al., 2013).
Interestingly, the levels of adult neurogenesis in the dentate
gyrus of the hippocampus have been associated with differential
functional roles dependant on its dorsal (posterior) or ventral
(anterior) location: dorsal neurogenic pool of hippocampal pro-
genitor cells is associated with learning and memory whereas
ventral—with motivational and emotional behaviors. The latter
one can be exemplified by the studies looking at neurogene-
sis in neuropsychiatric disorders, such as depression, in which
greater vulnerability to stress is reflected by a significant decrease
in the ventral hippocampus (Tanti and Belzung, 2013). Given
that neurogenesis is altered in the course of AD (for details
see review by Lazarov and Marr, 2013), and that dorsal neuro-
genesis is implicated in memory and learning, it is surprising
that only few studies have explored the role of dorsal-ventral
differences in AD and in hippocampal neurogenesis in the course
of AD.
Fuster-Matanzo et al. identified that overexpression of glyco-
gen synthase kinase-3β (GSK-3β), an enzyme involved in both AD
pathogenesis and neurodevelopment, leads to significant decrease
in the number of granular neurons and increased astrocytosis in
mice DG (Fuster-Matanzo et al., 2011). Notably, these changes
are spared in the ventral DG, where reduced GSK-3β activity
and less cell death compared with the dorsal area were found
(Fuster-Matanzo et al., 2011). Fuster-Matanzo et al. study has
elegantly demonstrated that there are regional differences in GSK-
3β activity in AD which might explain why dorsal hippocampus
is more susceptible to neurodegeneration (Fuster-Matanzo et al.,
2011).
In the 3xTg mice the level of proliferation was reduced com-
pared to non-Tg animals, and in the female mice it was present
predominantly in the dorsal than ventral hippocampus, whereas
the males exhibited first changes in neurogenesis in the ventral
hippocampus (Rodriguez et al., 2008). However, the authors did
not investigate if the number of new-born neurons is subregion-
dependent.
In another report, authors did not analyse neurogenesis but
presented interesting findings with regard to dorsal hippocam-
pus and spatial memory, for which the dorsal hippocampus is
essential. Yiu et al. found that TgCRND8 mice exhibit severe
impairment of spatial memory and presented with decreased
CREB activation in dorsal CA1, decreased spine density and
dendritic complexity of CA1 pyramidal neurons (Yiu et al., 2011).
They exhibited also decreased neuronal network activity.
These three studies point to the role of dorsal hippocampus in
AD. However, as mentioned already above, the anterior (ventral
in rodents) hippocampus, is the subregion, where the majority
of volume differences are reported in aMCI and AD patients.
Wolf et al. reported that atrophy of left posterior hippocampus
was better in discriminating controls from MCI (Wolf et al.,
2001). It is plausible that neurogenesis impairment in AD patients
affects predominantly mood, whereas circuits’ dysfunction under-
lies memory impairment and associated symptoms. Hence, the
described above dorsal-ventral (posterior-anterior) discrepancies
in the hippocampus role in the early stages of AD might be
reflected by neuropsychiatric symptoms which receive much less
attention than cognitive symptoms, but constitute a common
feature of AD (Lyketsos et al., 2011). Around 35–75% MCI
(Apostolova and Cummings, 2008) and 75% of AD patients
experience emotional symptoms, with depression and anxiety
as the most common ones during the prodromal disease stage
(Sturm et al., 2013). The most frequently observed neuropsychi-
atric features in MCI individuals are apathy, depression, anxiety,
irritability, whereas in AD patients apart from these same symp-
toms agitation/aggression is also present (Lyketsos et al., 2002;
Wadsworth et al., 2012; Dillon et al., 2013). It has been noticed
that these symptoms often precede and accelerate conversion to
dementia (Apostolova and Cummings, 2008; Wadsworth et al.,
2012; Dillon et al., 2013). For instance, depression has been shown
to double risk of conversion to AD (Modrego and Ferrández,
2004). Notably, emotional symptoms accompanying cognitive
problems are more common among future converters to AD
(Gallagher et al., 2011). However, neuropsychiatric symptoms do
not correlate with cognitive impairment (Dillon et al., 2013).
Notably, the data from AD animal models frequently does not
cover emotional symptoms, thus dorsal-ventral analysis might by
biased by focusing exclusively on the cognitive domain.
Another emotion-related AD feature is emotion contagion
which is a basic affective mechanism synchronizing physiological
and behavioral states with those of another to promote affective
simulation and altruistic behavior and is not dependant on higher
order cognitive processes. Anterior hippocampus has been associ-
ated in both MCI and AD patients with experiencing high levels
of emotional contagion (Sturm et al., 2013). Emotional contagion
was found to be weakly correlated with depression symptoms
(Sturm et al., 2013). It has been proposed that higher level of
emotional contagion might be due to less efficient inhibition
of emotions and salience network release which are associated
with smaller volume in primarily right-hemisphere temporal lobe
structures (Sturm et al., 2013).
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FUNCTIONAL HIPPOCAMPAL ABNORMALITIES IN AD
In the next section of the review, we focus on the link between
functional hippocampal changes and their predictive value for
AD, and we demonstrate the link between structural and func-
tional alterations is still unresolved. These changes could occur
sequentially or simultaneously and they might influence each
other, as we exemplify by showing the association between neu-
rogenesis and seizures.
HYPEREXCITABILITY AND SEIZURES AT EARLY AD STAGES
It has been reported that during memory tasks individuals
with mild AD show reduced hippocampal activity, whereas
aMCI and MCI patients exhibit hyperactivity in the hippocam-
pus/parahippocampal region (Hämäläinen et al., 2007; Miller
et al., 2008; O’Brien et al., 2010; Yassa et al., 2010; Putcha et al.,
2011). Task-related hyperactivity has been described in asymp-
tomatic carriers of AD pathological mutations during associative
encoding task (right anterior hippocampus; Quiroz et al., 2010);
in asymptomatic offspring of autopsy-confirmed AD patients
(Bassett et al., 2006); in cognitively intact young and old carri-
ers of APOE4 (Bookheimer et al., 2000; Dickerson et al., 2005;
Filippini et al., 2009) and in low-performing clinically healthy
aged individuals (Miller et al., 2008). Conversely, individuals at
late aMCI stage and early AD already express the hippocampal
hypoactivity pattern (Hämäläinen et al., 2007). During an asso-
ciative memory task hyperactivation of the anterior hippocampus
and EC in MCI patients compared to the controls was observed
(Dickerson et al., 2005). Recently, the characteristic pattern of
hyperactivity as well as shape and volume changes were detected
in the CA3/DG of aMCI patients (Yassa et al., 2010; Bakker et al.,
2012). CA3/DG network is essential for a key process for episodic
memory, pattern separation (described later in this review).
Initially this type of hyperactivity has been regarded as com-
pensation to deal with a cognitive task by recruiting additional
neuronal resources; however it is more likely that it reveals
neuronal excitotoxicity and in addition, the excess activation
directly contributes to memory impairment (Brewer et al., 1998;
Morcom et al., 2007; Putcha et al., 2011). There is an overall nega-
tive correlation between hippocampal activity and performance
on memory task in the aged individuals (Putcha et al., 2011).
Therefore, given that the network hyperexcitability contributes
to cognitive impairment, Bakker et al. have demonstrated that by
using a low dose of antiepileptic drug, levetiracetam, hippocampal
activation in aMCI was reduced to the level observed in the
control group and that had an impact on improved memory
performance (Bakker et al., 2012).
In AD patients as well as in several transgenic AD mouse
models spontaneous epileptic seizures have been observed (Velez-
Pardo et al., 2004; Rao et al., 2009; Noebels, 2011) and they
are attributed to the above-described increased network hyper-
excitability (Hazra et al., 2013). Hazra et al. suggested that the
seizures occur due to failure of inhibitory interneurons in DG to
generate action potentials which leads to impaired DG function
that is analogous to that observed in epilepsy. In addition, there is
increased synaptic facilitation in the perforant pathway, leading
to increased excitatory synaptic responses and spatiotemporal
hyperexcitability of the DG perforant pathway circuit, and as a
consequence a runaway excitation affecting hippocampal circuits
adjacent to DG, which is called “breakdown of DG” (Hsu, 2007;
Busche et al., 2008, 2012; Noebels, 2011; Hazra et al., 2013).
These phenomena have been attributed to the Aβ pathology that
has been linked with synaptic depression and to LTP inhibition
(Busche et al., 2008; Hazra et al., 2013).
The occurrence of seizures in AD might have serious impli-
cations for neurogenesis. Seizures have been shown to increase
neurogenesis, however they eventually decrease the survival of
new-born neurons which also show aberrant migration and
form aberrant circuits (see review by Parent and Murphy, 2008).
Recently, Hester and Danzer (2013) demonstrated that status
epilepticus similarly affects both dorsal and ventral hippocampus
integration of new-born granule neurons and mossy fiber sprout-
ing (Hester and Danzer, 2013).
Seizures are followed by comorbidities such as emotional diffi-
culties (including increased risk for depression), cognitive impair-
ment (memory problems) and behavioral problems, and at least
some of them originate in disrupted neurogenesis. Surprisingly,
there is considerable overlap between these symptoms and AD at
an early stage.
PATTERN SEPARATION IN AD
Hyperactivity in DG/CA3 region has been linked with age-related
mnemonic discrimination deficits, i.e., an inability to distinguish
between items and similar objects—so called lures in memory
(Yassa et al., 2011a). Aging is characterized by a shift in bias
from pattern separation to pattern completion in the DG/CA3
network and that correlates with changes in perforant pathway
integrity (Yassa et al., 2011b). Perforant pathway originates in
the layer II of EC and leads to granule cells in the DG which
send projections to CA3. That is an essential network for pattern
separation—encoding distinctive representations of experiences
that have overlapping features with prior memories (Gallagher
and Koh, 2011). DG plays an essential role in pattern sepa-
ration, whereas CA3 in pattern completion (Yassa and Stark,
2011).
As it has been already mentioned above, AD is characterized
by a degeneration of perforant pathway connections and com-
promised pattern separation circuit might lead to episodic mem-
ory impairment. Recently, Ally et al. reported that AD patients
demonstrate impaired both pattern separation and completion,
whereas individuals with aMCI, depending on the lag between
tasks, behaved similarly to the controls (if the lag was short) or
to AD patients (if the lag was long) which indicates a rapidly
degrading visual memory representation in aMCI (Ally et al.,
2013). Therefore, the authors proposed that aMCI is characterized
by rapid forgetting, whereas dementia due to AD is a disorder of
encoding. Moreover, in 12-month old Tg2576 AD mice expres-
sion of mutant human APP led to disruption of DG/CA3 network,
which is proposed as critical for pattern separation (Palmer and
Good, 2011).
There is also accumulating data showing that hippocam-
pal neurogenesis is an important player for pattern separation
(Aimone et al., 2010, 2011; Sahay et al., 2011a,b; Tronel et al.,
2012). Therefore, it is plausible that neurogenesis alterations in
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the course of AD are contributing to impairment of pattern
separation, however, it remains to be investigated.
Given that the volume of the posterior hippocampus positively
correlates with memory for very detailed contextual information
(temporal and spatial relations; representation at fine granulari-
ties), whereas anterior hippocampus is responsible for a coarse,
global representation (spatial locales or contexts, coarse repre-
sentation), it has been proposed that posterior hippocampus is
biased towards pattern separation, whereas anterior hippocampus
is more suited for pattern completion (Poppenk and Moscovitch,
2011; Evensmoen et al., 2013; Poppenk et al., 2013). Moreover,
Poppenk and Moscovitch (2011) suggested that the posterior,
but not the anterior hippocampus, is closely linked to episodic
memory retrieval through its connection with the DMN, includ-
ing pregenual anterior and PCC, and precuneus (Poppenk and
Moscovitch, 2011). It remains to be explored how the reported
decrease in the anterior hippocampal volume observed in AD
corresponds with these hypotheses.
CONCLUSIONS
There is considerable evidence that hippocampal volume
decreases early during AD progression. However, these symp-
toms are not specific enough to fulfil criteria of AD biomarkers
and enable presympromatic AD diagnosis. In this review, we
present current data on detailed subfield and subregion analyses
of the hippocampus and we demonstrate that so far, there is
no consensus on which subfield could become a reliable early-
stage disease biomarker. There are discrepancies in the analysed
cohorts, methodology (labor-intensive and suffering from intra-
and interobserver variability manual segmentation vs. automatic
segmentation protocols; using T1-weighted MRI sequences at
1.5–3 Tesla that lack the contrast and resolution to distinguish e.g.,
CA4/DG region vs. T2-weighted MRI), using single or multiple
MRI scans over time, anatomical labelling (e.g., in delineating
the border between the anterior and posterior hipocampus),
and that all prevents direct comparisons between studies. For
instance, Nestor et al. argue that absolute volume differences
between different protocols may vary by > 30% (Nestor et al.,
2012). Our review indicates that apart from hippocampal sub-
field volumetry, there is another promising candidate for early
AD biomarker which is the characteristic pattern of hippocam-
pal hyperactivation associated with seizures and neurogenesis
changes. The relation between these phenomena demands also
further in depth investigations as it might unravel a very impor-
tant early disease target for therapeutic intervention. Finally, we
believe that improving harmonization of different MRI protocols
and in depth analysis of neurogenesis changes in the course of AD
might result in development of new disease cellular and molecular
signatures.
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